Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $615 Billion
  • Q3 2024

Adar1 Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $615 Billion distributed in 278 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $48.1B, Protagonist Therapeutics, Inc with a value of $44.2B, Bridge Bio Pharma, Inc. with a value of $36.9B, Ea Series Trust with a value of $35.2B, and Roivant Sciences Ltd. with a value of $34.9B.

Examining the 13F form we can see an increase of $85.2B in the current position value, from $530B to 615B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $615 Billion
Healthcare: $433 Billion
ETFs: $6.5 Billion
Communication Services: $3.51 Billion
Utilities: $1.26 Billion
Technology: $995 Million
Industrials: $511 Million
Real Estate: $132 Million
Basic Materials: $121 Million
Other: $293 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Korro Bio Inc
-
$1.65 Billion 0.27% of portfolio
-
Q3 2024 Added 585.87%
Instil Bio Inc
-
$1.6 Billion 0.26% of portfolio
-
Q3 2024 New
$246M
$1.63 Billion 0.26% of portfolio
302,212
Q3 2024 New
Ares Acquisition Corp Ii
-
$1.51 Billion 0.24% of portfolio
-
Q3 2024 New
$24.2B
$1.19 Billion 0.19% of portfolio
10,000
Q3 2024 New
$5.15B
$1.15 Billion 0.19% of portfolio
10,097
Q3 2024 Reduced 17.58%
$1.91B
$1.18 Billion 0.19% of portfolio
23,457
Q3 2024 Added 388.69%
$31.1M
$1.17 Billion 0.19% of portfolio
348,263
Q3 2024 Added 72.64%
Disc Medicine Inc
-
$1.11 Billion 0.18% of portfolio
-
Q3 2024 New
$2.48B
$1.1 Billion 0.18% of portfolio
27,903
Q3 2024 Added 493.68%
$709B
$1.02 Billion 0.17% of portfolio
1,150
Q3 2024 New
Kezar Life Sciences Inc
-
$1.03 Billion 0.17% of portfolio
-
Q3 2024 New
$60M
$1.07 Billion 0.17% of portfolio
903,959
Q3 2024 Added 57.99%
$8.73B
$1.04 Billion 0.17% of portfolio
15,200
Q3 2024 Added 2,433.33%
Avadel Pharmaceuticals PLC
-
$1.06 Billion 0.17% of portfolio
-
Q3 2024 New
$3.73B
$1.07 Billion 0.17% of portfolio
10,442
Q3 2024 New
Ibio Inc
-
$1.06 Billion 0.17% of portfolio
-
Q3 2024 Reduced 16.45%
Bicara Therapeutics Inc
-
$1.03 Billion 0.17% of portfolio
-
Q3 2024 New
$142M
$1.03 Billion 0.17% of portfolio
93,284
Q3 2024 Reduced 32.48%
$1.69B
$1.08 Billion 0.17% of portfolio
43,900
Q3 2024 Reduced 39.7%
$7.87B
$980 Million 0.16% of portfolio
13,400
Q3 2024 New
$41.4M
$996 Million 0.16% of portfolio
743,459
Q3 2024 Reduced 19.1%
$2.95B
$946 Million 0.15% of portfolio
21,300
Q3 2024 New
$632M
$910 Million 0.15% of portfolio
54,358
Q3 2024 Added 2.06%
$87.1B
$915 Million 0.15% of portfolio
1,850
Q3 2024 New
$1.64B
$940 Million 0.15% of portfolio
24,100
Q3 2024 New
$81.1B
$916 Million 0.15% of portfolio
871
Q3 2024 New
$212M
$945 Million 0.15% of portfolio
182,166
Q3 2024 New
$1.2B
$852 Million 0.14% of portfolio
25,900
Q3 2024 New
Agriculture & Nat Sol Acq CO
-
$832 Million 0.14% of portfolio
-
Q3 2024 New
$109M
$832 Million 0.14% of portfolio
163,443
Q3 2024 Added 67.3%
$9.15B
$887 Million 0.14% of portfolio
7,100
Q3 2024 Added 59.55%
$13.9B
$823 Million 0.13% of portfolio
23,000
Q2 2024 New
Keen Vision Acquisition Corp
-
$805 Million 0.13% of portfolio
-
Q4 2023 New
$2.81B
$742 Million 0.12% of portfolio
20,000
Q3 2024 New
$978M
$740 Million 0.12% of portfolio
53,111
Q3 2024 Added 51.31%
$290M
$716 Million 0.12% of portfolio
220,906
Q3 2024 Added 105.87%
$29.4M
$733 Million 0.12% of portfolio
373,835
Q3 2024 Reduced 42.06%
Kiora Pharmaceuticals Inc
-
$719 Million 0.12% of portfolio
-
Q3 2024 Added 13.88%
$456M
$732 Million 0.12% of portfolio
40,290
Q2 2024 Added 0.5%
$3.62B
$684 Million 0.11% of portfolio
30,000
Q3 2024 New
$277M
$656 Million 0.11% of portfolio
73,663
Q3 2024 Reduced 63.76%
$1.3B
$660 Million 0.11% of portfolio
23,007
Q3 2024 Reduced 9.8%
$3.99B
$626 Million 0.1% of portfolio
20,000
Q3 2024 Added 66.67%
$1.06B
$586 Million 0.1% of portfolio
30,000
Q3 2024 New
Nabors Energy Transition Cor
-
$639 Million 0.1% of portfolio
-
Q3 2024 New
$2.03B
$591 Million 0.1% of portfolio
13,000
Q3 2024 Added 64.74%
$2.3B
$561 Million 0.09% of portfolio
11,856
Q3 2024 Reduced 76.58%
Indivior PLC
-
$527 Million 0.09% of portfolio
-
Q3 2024 Reduced 22.78%

Summary

  • Portfolio
  • No. of Stocks 278
  • Current Value $615 Billion
  • Prior Value $530 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 89 stocks
  • Additional Purchases 75 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 70 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email